Cigna Corp. (CI) February weekly 300 straddle into quarter results

Go back to Cigna Corp. (CI) February weekly 300 straddle into quarter results

CIGNA (CI) PT Raised to $360 at Goldman Sachs

February 5, 2024 7:22 AM EST

Goldman Sachs analyst Nathan Rich raised the price target on CIGNA (NYSE: CI) to $360.00 (from $352.00) while maintaining a Neutral rating.

The analyst comments "CI outperformed (+5.4% on 2/2 vs S&P +1.1%) after reporting 4Q23 EPS 3%/4% above GS/consensus (FactSet), raising its 2024 EPS guidance by ~1% to >$28.25 from >$28.00, and reemphasizing its prioritization of share repurchases as... More

Cigna Corp. (CI) lifted by Deutsche Bank following 'value-unlocking transaction'

February 1, 2024 1:13 PM EST

Shares of Cigna Corp. (NYSE: CI) rose more than 1% Thursday after the stock was upgraded to Buy from Hold at Deutsche Bank. Analyst George Hill raised the price target to $370 from $355 per share.

The upgrade follows CI announcing the agreement to sell its MA,... More

Deutsche Bank Upgrades CIGNA (CI) to Buy

February 1, 2024 5:18 AM EST

Deutsche Bank analyst George Hill upgraded CIGNA (NYSE: CI) from Hold to Buy with a price target of $370.00 (from $355.00).

The analyst comments "Upgrading CI Shares to Buy: We are upgrading CI shares to Buy and increasing our price target to $370 from $355, reflecting 13x (up from 12.5x) our 2024 EPS estimate of $28.42. We have increased... More